Elicio Therapeutics, Inc. Analyst EPS Estimates
Quarter | Number of Estimates | Low Estimate | High Estimate | Average Estimate |
---|---|---|---|---|
Q1 2024 | 0 | -$1.09 | -$1.09 | -$1.09 |
Q2 2024 | 0 | -$0.96 | -$0.96 | -$0.96 |
Q3 2024 | 2 | -$0.95 | -$0.67 | -$0.81 |
Q4 2024 | 0 | -$0.79 | -$0.79 | -$0.79 |
Q1 2025 | 1 | -$0.82 | -$0.82 | -$0.82 |
Q2 2025 | 1 | -$0.76 | -$0.76 | -$0.76 |
Q3 2025 | 1 | -$0.77 | -$0.77 | -$0.77 |
Q4 2025 | 1 | -$0.78 | -$0.78 | -$0.78 |
Elicio Therapeutics, Inc. Earnings Date And Information
Elicio Therapeutics, Inc. last posted its earnings results on Tuesday, August 13th, 2024. The company reported $-0.64 earnings per share for the quarter, topping analysts' consensus estimates of $-0.96 by $0.32. The company had revenue of 0 for the quarter and had revenue of 0 for the year. Elicio Therapeutics, Inc. has generated $-7 earnings per share over the last year ($-6.96 diluted earnings per share) and currently has a price-to-earnings ratio of -1.48. Elicio Therapeutics, Inc. has not formally confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based on prior year's report dates.
Elicio Therapeutics, Inc. Earnings History by Quarter
Date | Quarter | Consensus Estimate | Reported EPS | Beat/Miss | Revenue Estimate | Actual Revenue |
---|---|---|---|---|---|---|
08/13/2024 | Q2 2024 | -$0.96 | -$0.64 | 0.32 | $0 | $0 |
03/30/2024 | Q1 2024 | -$1.15 | $0 | $0 | ||
12/30/2023 | Q4 2023 | -$0.93 | $0 | |||
09/29/2023 | Q3 2023 | -$1.27 | $0 | |||
06/29/2023 | Q2 2023 | -$2.44 | $800,000 | $0 | ||
03/30/2023 | Q1 2023 | -$2.51 | $0 | |||
12/30/2022 | Q4 2022 | -$2.15 | $0 | |||
09/29/2022 | Q3 2022 | -$2.27 | $625,000 | $0 | ||
06/29/2022 | Q2 2022 | -$232.03 | $0 | |||
03/30/2022 | Q1 2022 | -$4.75 | $1.65 M | |||
12/30/2021 | Q4 2021 | $4.97 | $25.94 M | |||
09/28/2021 | Q3 2021 | -$5.26 | $1.46 M | |||
03/30/2021 | Q1 2021 | -$0.47 | $0 | |||
03/30/2020 | Q1 2020 | -$0.44 | $0 |
Elicio Therapeutics, Inc. Earnings: Frequently Asked Questions
-
When is Elicio Therapeutics, Inc.'s earnings date?
Elicio Therapeutics, Inc. has not confirmed its next earnings publication date, but the company's estimated earnings date is Thursday, November 7th, 2024 based off last year's report dates.
-
Did Elicio Therapeutics, Inc. beat their earnings estimates last quarter?
In the previous quarter, Elicio Therapeutics, Inc. (:ELTX) reported $-0.64 earnings per share (EPS) to beat the analysts' consensus estimate of $-0.96 by $0.32.
-
How can I listen to Elicio Therapeutics, Inc.'s earnings conference call?
The conference call for Elicio Therapeutics, Inc.'s latest earnings report can be listened to online.
-
How can I read Elicio Therapeutics, Inc.'s conference call transcript?
The conference call transcript for Elicio Therapeutics, Inc.'s latest earnings report can be read online.
-
How much profit does Elicio Therapeutics, Inc. generate each year?
Elicio Therapeutics, Inc. (:ELTX) has a recorded net income of $0. Elicio Therapeutics, Inc. has generated $-6.96 earnings per share over the last four quarters.
-
What is Elicio Therapeutics, Inc.'s price-to-earnings ratio?
Elicio Therapeutics, Inc. (:ELTX) has a price-to-earnings ratio of -1.48 and price/earnings-to-growth ratio is -0.06.